To veterinarians, horse owners and university officials,

CEO Charlie Owen once again is being inundated with emails requesting help for laminitic horses. He’s been responding to them personally as fast as he can, but we feel the need to announce that we cannot treat more horses at this time with Laminil. Data collection has been completed, and we are restricted by the FDA in what we can do with an investigational drug. We simply cannot sell Laminil without FDA approval.

This is very hard on us emotionally. The horses and donkeys treated with Laminil this spring did extremely well, and it’s difficult to tell owners of other laminitic horses that we can’t help their animals.

To move Laminil forward will take money and a few more months of time.

We would extremely grateful if you can help us move Laminil along.

It is a great product. Listen to the people who have used it. Tell your peers.

The Laminil team